Intrahepatic cholangiocarcinoma represents the second most common primary liver cancer
and is increasing in incidence. Most patients are diagnosed at an advanced, nonsurgical …

In the oncology landscape, cholangiocarcinoma is a challenging disease in terms of both
diagnosis and treatment. Besides anamnesis and clinical examination, a definitive diagnosis …

Background The objective of this study was to investigate the characteristics, treatment and
prognosis of early versus late recurrence of intrahepatic cholangiocarcinoma (ICC) after …

Background Chemotherapy is frequently used in cholangiocarcinoma as an adjunct to
surgical resection, but the appropriate sequence of chemotherapy with surgery is unclear …

Background Lymphadenectomy ensures accurate staging for patients with intrahepatic
cholangiocarcinoma, especially for those without preoperatively suspected positive lymph …

Introduction and aims. Cholangiocarcinomas are a heterogeneous group of tumors that can
be classified into three clinically distinct types of cancers, intrahepatic, perihilar and distal …

Background Upfront surgery is the current standard for resectable intrahepatic
cholangiocarcinoma (ICC) despite high treatment failure with this approach. We sought to …

Introduction Cholangiocellular carcinoma (CCA) is an aggressive malignancy with a dismal
prognosis. Among curative treatment options for CCA, radical surgical resection with …

Background While surgery is a mainstay of curative-intent treatment for patients with
intrahepatic cholangiocarcinoma (IHC), the role of neoadjuvant therapy (NT) has not been …

Background The benefit of adjuvant chemotherapy for resected intrahepatic
cholangiocarcinoma (ICC) is unclear. The aim of the current study was to investigate the …